The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lee Sung since 2024.
This trader's CIK number is 1793200.
At the time of last reporting, Lee Sung was the EVP, Chief Financial Officer of Cytokinetics Inc. (stock ticker symbol CYTK).
Also see all insider trading activities at Cytokinetics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | CYTK | 0 | $0 | 4,935 | $306,710 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | VIR | 0 | $0 | 6,008 | $59,407 | 0 | $0 |
2. Vir Biotechnology, Inc. (VIR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-17 | CYTK | Sale | 4,935 | 62.15 | 306,710 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-27 | VIR | Sale | 6,008 | 9.89 | 59,407 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lee Sung (EVP, Chief Financial Officer of Cytokinetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.